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Orlistat, a selective inhibitor of gastrointestinal lipases, was used to investigate triacylglycerol 
absorption. Using mice and a variety of emulsified dietary lipids we found that the absorption of 
radiolabelled tripalmitin (containing the fatty acid 16: 0), but not of triolein (18 : ln-9) or tri-y-linolenin 
(18:3n-6), was incomplete from meals rich in esterified palmitate. Further, the absorption of 
radiolabelled triq-linolenin, from both saturated and unsaturated dietary triacylglycerols, was 1.3- to 2 
fold more potently inhibited by orlistat than that of triolein and tripalmitin. These radiolabelled 
triacylglycerols, which have the same fatty acid in all three positions, may not always be accurate 
markers of the absorption of dietary triacylglycerols. Orlistat was more effective at inhibiting the 
absorption of radiolabelled triacylglycerols with which it was codissolved than those added separately, 
which indicates that equilibration between lipid phases in the stomach may not always be complete. The 
saturation of the dietary lipid had little or no effect on the potency of orlistat. Orlistat provides a novel 
approach for studying the role of triacylglycerol hydrolysis in the overall process of triacylglycerol 
absorption. 
Lipase inhibitor: Triacylglycerol: Absorption: Mice 
Dietary triacylglycerols can only be absorbed after they have been hydrolysed by 
gastrointestinal lipases to give fatty acids and monoacylglycerols (Nelson & Ackman, 
1988). In vitro, different triacylglycerols are hydrolysed at different rates; for example, 
triacylglycerols that contain less common or long-chain, saturated fatty acids are 
hydrolysed more slowly (Brockerhoff, 1970; Lawson & Hughes, 1988; Bergstedt et QZ. 1990, 
1991; Yang et al. 1990). In vivo the rate of fatty acid absorption depends on the 
physicochemical properties both of the individual fatty acids and of the dispersion that they 
form with the fats and other components in the diet (Ockner et al. 1972; Carey et al. 1983). 
The site of absorption has also been found to depend on the rate of absorption; 
triacylglycerols that are more slowly absorbed, for example those with long-chain, 
saturated fatty acids, tend to have a more distal site of absorption (Bergstedt et al. 1990, 
1991). However, the large excess of both pancreatic (EC 3.1.1.3) and carboxyl ester lipase 
(EC 3.1.1.13) combined with the large surface area of the intestine ensure that even alkyl 
esters with low rates of hydrolysis are efficiently absorbed (Nelson & Ackman, 1988; Chen 
et al. 1989; Yang et al. 1990). 
Orlistat is a selective and potent inhibitor of lipases that acts solely in the intestinal lumen 
and does not inhibit the absorption of oleic acid (Borgstrom, 1988; Hadvary et aZ. 1988, 
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1991; Fernandez & Borgstrom, 1989; Luthi-Peng et al. 1992). It inactivates the lipase by 
reacting covalently with the serine ( S e ~ - l ~ ~ )  in the active site. Orlistat has been shown to 
reduce hypertriacylglycerolaemia and obesity in animals (Hogan et al. 1987; Meier et al. 
1991) and its effectiveness in man is undergoing clinical investigation (Drent et al. 1992; 
Hauptmann et al. 1992). 
Our aim was to use orlistat in order to study the relative efficiency with which a variety 
of emulsified dietary lipids are absorbed in mice, and in particular to answer the following 
questions : fmt, whether radiolabelled triacylglycerols, such as triolein (containing the fatty 
acid 18 : ln-9), tri-y-linolenin (18 : 3n-6) and tripalmitin (1 6 : 0), are suitable markers for the 
absorption of dietary triacylglycerols ; and second, under conditions where triacylglycerol 
hydrolysis is impaired, whether the absorption of these radiolabels is affected by the nature 
of the dietary fat in which they are dissolved. 
MATERIALS AND METHODS 
Materials 
[14C]Triolein (glycerol-tri[ l-14C]oleate, 2 GBq/mmol), [14C]tripalmitin (glycerol-tri[ 1-14C]- 
palmitate, 2 GBq/mmol), [ l-14C]oleic acid (2 GBq/mmol) and [14C]dioleoyl-phosphatidyl- 
choline (1,2-di[ 1 -'4C]oleyl-3-phosphatidylcholine, 4 GBq/mmol) were obtained from 
Amersham International plc (CH-8058, Zurich, Switzerland), [3H]triolein (glycerol-tri[9,10- 
3H]oleate, 992 GBqjmmol) from NEN Research Products Du Pont de Nemours 
International S.A., CH-8058 Zurich, Switzerland, and [14C]tri-y-linolenin (glycerol-tri- 
[1-14C]-6,9,12-~~tadecatrienoate, 7 GBqlmmol) was prepared by Dr H. Harder at 
F. Hoffmann-La Roche, Basel, Switzerland. Briefly, [14C]tri-y-linolenic acid was prepared 
by treating l-chloro-5,8,1l-heptadecatriene with Rieke's magnesium (Rieke & Bales, 1974) 
and allowing the resulting Grignard intermediate to absorb 14C0, ; [14C]tri-y-linolenin was 
prepared by reacting the [14C]tri-y-linolenic acid with glycerol in the presence of 
dimethylaminopyridine and dicyclohexylcarbodiirnide. The [14C]tri-y-linolenin was stored, 
in portions sufficient for one experiment, in sealed ampoules under Ar. Radioactive purity 
was checked by TLC using precoated silica-gel plates (HPTLC 60; Merck (Schweiz) AG, 
CH-8029 Zurich, Switzerland) and di-isopropylether-heptane-acetic acid (48 : 32 : 1.6) 
for triacylglycerols, chloroforn-methanol-acetic acid-water (65 : 50 : 4 : 1) for 
phosphatidylcholine, and heptane-isopropyl ether-acetic acid (60 : 40 : 4) for oleic acid. 
Radioactive purity was at least 97 'YO. [1,2-3H]polyethyleneglycol 4000 was from NEN 
Research Products. 
Linseed oil was from a local pharmacy, olive and sunflower oils, cream and skimmed 
milk powder were from a supermarket, palm and coconut oils were from Tensochema AG, 
Zurich, Switzerland, borage oil was from Roche Lipid Technology, Heanor, Derbyshire 
and egg phosphatidylcholine was from Lipid Products, South Nutfield, Surrey. Orlistat 
(Ro 18-0647/002, MW 496) was obtained by chemical synthesis (Barbier & Schneider, 
1987). All other reagents were of analytical grade or the purest available. 
Animals 
Female, MORO (Ibm), albino mice (about 25 g; twenty to thirty mice per experiment) were 
maintained on chow (Kliba 25-331 ; Klibamuhle, Kaiseraugst, Switzerland) and water ad 
lib. They were kept individually in wire-mesh cages under a 12 h light-12 h dark cycle. 
Preparation of the test meals 
The radiolabelled triacylglycerols, with or without orlistat, were dissolved in the cream and 
in the plant oils, under a stream of N,, by stirring for about 30 min at room temperature 
(at 65" for [14C]tripalmitin) to give about 0.037 MBq/g plant oil and cream fat. 
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Table 1. Approximate fatty acid composition (g/100 g total fatty acids), iodine values and 
melting points (") of the dietary fats 
Palm Coconut Olive Sunflower- Borage Linseed 
oil*? oil? Cream*? oil* seed oil* oils oil* 
~ 
Polyunsaturated 
Linoleic 10 2 2 8 69 36 15 
Linolenic 1 1 2 1 0 23 53 
Oleic 37 7 23 74 19 16 21 
Others 0 0 7 3 1 8 0 
Monounsaturated 
Saturated 
< Cl? 2 80 21 0 tl 0 < 1  
' c,, 3 2 0 2 4 5 5 Palmi tic 45 8 45 12 7 12 6 
Iodine value 53 9 34 90 131 166 210 
Melting points 40 27 -4 - 25 -28 -30 
* Wissenschaftliche Tabellen Geigy (1977). 
t According to the suppliers. 
$ Raederstorff & Moser (1992). 
8 For details of procedure, see p. 854. 
The liquid test meals contained (g/kg) either starch 25, glucose 240, defatted milk 
powder 120, plant oil 76 and 150 mM-NaC1 solution 539, or, in order to obtain an 
equivalent composition, starch 18, glucose 173, defatted milk powder 87, cream 333 (i.e. 
76 g fat/kg) and NaCl solution 389. The fatty acid compositions of the dietary fats are 
given in Table 1. A stable emulsion was made by suspending the milk powder, glucose and 
starch in the NaCl solution, adding the dietary fat and blending in a glass-on-glass 
homogenizer for 30 s (2 min for cream). As described below, these test meals contained one, 
or more usually, two radiolabelled triacylglycerols. 
After preparation the test meals were stored at -20". On the day of use they were thawed 
and reblended (30s). On both the day of preparation and of use the stability of the 
emulsions and the uniform distribution of the markers were checked by measuring the 
radioactivity of at least five samples from different sites within the emulsion. 
Administration of test meals and orlistat suspensions 
The vehicle in which orlistat was dispersed contained 50 g gum arabic plus 50 g milk 
powder/l in water. 
The mice were divided into groups of three. After a 24 h fast, each mouse was orally 
administered about 250 pl(l0 ml/kg body weight) of the liquid test meal followed directly 
by about 250 ,ul of the above vehicle. Depending on the experimental design the orlistat was 
either dissolved in the fat of the test meal or suspended in the vehicle. Each group received 
a different dose of orlistat (1, 3, 10, 30, 100 or 1000 pmol/kg body weight). The mice were 
then given free access to their normal chow, and the faeces eliminated by each mouse during 
the next 31 h were collected. The test meals were administered at 09.00 hours, 3 h after the 
beginning of the 12 h day. 
For the experiment shown in Fig. 1, [3H]triolein (about 00037 MBq/ml test meal) was 
incorporated into the dietary lipid and either [ l-'4C]oleic acid or di[ l-14C]oleoyl- 
phosphatidylcholine (about 0.0037 MBq/ml test meal) into the aqueous phase of the test 
meal. 
The results in Tables 2 and 3 derive from two series of experiments. In the first the I4C- 
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radiolabelled triacylglycerols (about 0-0037 MBq/ml test meal) were incorporated into the 
dietary lipid and [3H]polyethyleneglycol (about 0.00074 MBq/ml test meal) was added to 
the aqueous phase of the test meal. This showed that during a 31 h collection period 91 to 
102 % of the nonabsorbable marker [3H]polyethyleneglycol was eliminated in the faeces. 
Further, it was found that at doses of orlistat sufficient to give approximately 80% 
inhibition of [14C]triolein absorption there was no separation of the water-soluble 
[3H]polyethyleneglycol from the lipid-soluble [14C]triolein during the intestinal transit. In 
the second series, which accounts for about half the ID,, values in Table 3 and all the results 
in Fig. 2, [3H]triolein (about 0.037 MBq/ml test meal) and one of the [14C]radiolabelled 
triacylglycerols (about 0.037 MBq/ml test meal) were incorporated into the test meals. 
In the experiment described in Table 5 the mice were orally administered two liquid test 
meals (about 250 pl) in which olive oil was the dietary lipid. In addition, the first test meal 
contained both [3H]triolein and orlistat whereas the second, which was administered 
immediately afterwards, contained [14C]triolein alone. 
Measurement of radioactivity in faeces 
The 3H- and 14C-radioactivity in the dried faeces was separated in a Packard sample 
oxidizer (Canberra Packard S.A., CH-8038 Zurich, Switzerland) and measured by liquid 
scintillation counting. The radioactivity eliminated in the faeces was expressed as a 
percentage of that in the test meal. 
Melting points 
The melting points of the dietary lipids were measured in a Mettler 2000B differential 
scanning calorimeter (Mettler-Toledo AG, CH-8606 Nanikon, Switzerland) (see Table 1). 
The samples were cooled from 22" (60" for palm and coconut oils) to - 70°, and then heated 
at S"/min. The melting point was taken as the temperature at the peak of the main 
endothermic transition. 
Analysis of the data 
In the absence of a theoretical model, an exponential relationship between dose and 
response was assumed in which both the maximal elimination of radiolabel in the faeces 
(max) and the orlistat dose required for half maximal elimination of radiolabel (ID,,) were 
determinable parameters. A least-squares, nonlinear curve-fitting procedure was used to fit 
the parameters max and ID,, in equation 1 to the data from each experiment (e.g., Fig. 1) 
other than those in which the elimination of radiolabelled triacylglycerol was not 
approximately zero in the absence of orlistat. In the latter case the parameters max, ID,, 
and min (orlistat-independent elimination of radiolabel) in equation 2 were fitted to the 
data. The average ID,, for a given radiolabelled triacylglycerol is the mean of these values 
(Table 3). 
y = max - max/exp (0*693x/ID,,) 
y = max - max/exp (0.693xlID ,) + min, 
(1) 
(2) 
where y is the radiolabel eliminated in the faeces (as a percentage of that administered) and 
x is the dose of orlistat. 
In experiments where the effect of orlistat on the elimination of two radiolabelled 
triacylglycerols was compared by giving them together, the results were also analysed by 
linear regression (Fig. 2). 
Statistics 
The results in Tables 2 and 5 are expressed as the mean, with the SEM, from the indicated 
number of mice. The ID,, values in Table 3 are the mean, with the SEM, from the indicated 
number of experiments, each of which was made on a different day. To determine an ID,,, 
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three mice were used at each of, typically, three different orlistat doses. Statistical 
significance of differences was assessed by Student's t test. 
R E S U L T S  
The experiments were designed to test the effect of orlistat, a lipase inhibitor, on the 
absorption of different dietary lipids (Table 1) from liquid test meals in mice. The test meals 
were orally administered. The orlistat was either incorporated into the meal (in meal) or 
administered immediately after the meal (post meal). Absorption was assessed by using 
radiolabelled triacylglycerols with different degrees of saturation ([14C]tri-y-linolenin, 
[3H]triolein and [14C]tripalmitin). For comparative purposes, the dietary oils have been 
classified as high- and low-melting-point oils (above and below O", see Table 1). 
As seen from the amount of radiolabel in the faeces of untreated mice (Table 2), the 
absorption of [14C]tri-y-linolenin and [3H]triolein from the tested dietary lipids was > 97 % 
and in general lay between 98 and 99%. In contrast, although the absorption of 
['4C]tripalmitin was > 97 % when the dietary lipid was olive oil or coconut oil, it was only 
about 90% when the dietary lipid was cream or palm oil (Table 2). The lipase inhibitor 
orlistat dose-dependently inhibited the absorption of these radiolabelled triacylglycerols 
(e.g. ['Hltriolein in Fig. 1) but not that of either [14C]oleic acid (Fernandez & Borgstrom, 
1989; see also Fig. 1) or of [14C]phosphatidylcholine (Fig. 1). However, the amount of 
orlistat required for the half-maximal inhibition of radiolabelled triacylglycerol absorption 
(ID5,) depended on whether the orlistat was given in the meal or immediately afterwards, 
on which of the radiolabelled triacylglycerols was used and, to a certain extent, on the 
dietary lipid (Table 3). 
In-meal v. post-meal administration of orlistat 
When orlistat was given in the test meal its ID,, was about three times smaller than when 
it was given immediately afterwards. This difference, which was highly significant 
(P = O.OOOl), was found irrespective of which of the radiolabels was used and of whether 
the dietary lipid had a high or low melting point (Table 3). For example, for [14C]tri-y- 
linolenin the ID,, was 2-4 pmollkg body weight when the orlistat was gven in the test meal 
and 5-12 pmol/kg when given immediately afterwards (Table 3) .  
Dependence of the determined ID,, on the radiolabelled marker 
The ID,, for inhibiting the absorption of [3H]triolein and [14C]tripalmitin when the dietary 
oil had a high melting point was, for a given mode of orlistat administration, essentially the 
same (Table 3 ; the absorption of [3H]tripalmitin from test meals with low-melting-point 
dietary lipids was not studied). In contrast, and irrespective of the mode of orlistat 
administration, the ID,, for the inhibition of [3H]triolein absorption was larger than that 
for [14C]tri-y-linolenin, by a factor of about 1-3 from test meals containing dietary oils with 
a high melting point and by a factor of about 2 from those containing oils with a low 
melting point (Table 3) .  Similarly, the ID,, for the inhibition of [14C]tripalmitin absorption 
from test meals containing dietary oils with a high melting point was 1.3- to 1.5-fold larger 
than that for [14C]tri-y-linolenin (Table 3). These differences were significant (Table 4). 
Dependence of the determined ID,, on the dietary lipid in the test meal 
The ID,, for the inhibition of [3H]triolein absorption was not affected by the melting point 
of the dietary lipid, neither was that of [14C]tri-y-linolenin when the orlistat was given after 
the test meal (Table 3). However, when orlistat was given in the meal, the ID,, for ["C]tri- 
y-linolenin was about l.5-fold larger from test meals containing lipids with higher as 
opposed to lower melting points (P = 0.012, Table 3). 
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Table 2. Effect of dietary lipid type on the loss of ['4C]tri-y-linolenin, [3H]triolein and 
['4Cltripalmitin in faeces of control mice* 
(Mean values with their standard errors) 
Faecal loss [14C]trilinolenin [3H]tnolein [14C]tripalmitin 
n Mean SE n Mean SE n Mean SE 
(expressed as % intake). . . 
=A .r .A -7 I 
Palm oil 23 
Coconut oil 12 
Cream 3 
Olive oil 3 
Sunflower-seed oil 6 
Borage oil 6 
Linseed oil 2 
1.7 0.1 39 2.8 0 2  22 9.7 0 8  
1.4 0 1  18 1.4 0.1 12 2 7  0.7 
1.1 0.1 9 1.7 0.2 6 9.0 1.5 
1.9 0 1  9 0.7 0.4 3 1.3 0 2  
1.3 0.2 3 0.9 0 0  
2.1 0.1 6 2.2 0 2  
1.0 0.1 5 1.6 0 1  
* For details of procedures, see pp. 852-854. 
u) 
Q 
([I 
8 80 
w- 
10 100 1000 
Orlistat (prnolkg) 
Fig. 1. Effect of the lipase inhibitor orlistat on the elimination of [*H]triolein (O), [14C]phosphatidylcholine (m) 
and [14C]oleic acid (A) in the faeces of mice. Each mouse was given one of two test meals by oral administration. 
These contained olive oil and either [3H]triolein plus [14Clphosphatidylcholine or [3H]triolein plus ['*C]oleic acid. 
The orlistat was given immediately afterwards by oral administration. At each dose, each of the test meals was 
given to three mice. Values are means for six observations for [3H]triolein and three observations for both 
[14C]phosphatidylcholine and ['qC]oleic acid. For details of test meals, see pp. 852-854. 
Direct comparison of the absorption of two radiolabelled triacylglycerols from the same 
test meal 
3H- and 14C-radiolabelled triacylglycerols were incorporated into the same test meal in 
order to eliminate any variations in the sensitivity of individual mice to the effect of orlistat 
on triacylglycerol absorption. The data were plotted as the percentage of the 14C-radiolabel 
recovered in the faeces against that of the 3H-radiolabel, irrespective of the orlistat dose. 
The elimination of [14C]triolein plotted against that of [3H]triolein had, as expected, a slope 
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'0 20 40 60 80 100 
Radiolabel eliminated from 
[3Hltriolein (%) 
L 
' 0  20 40 60 80 100 
0 
0 
OO ;o bo $0 i o  d o  
Radiolabel eliminated from 
[3Hltriolein (%) 
Fig. 2. Comparison of the effect of the lipase inhibitor orlistat on the elimination in the faeces of [14C]tri-y- 
linolenin, [l4CC]tripalmitin and [14C]triolein with that of rH]triolein from test meals containing different lipids. The 
mice were orally administered a test meal containing orlistat and [3H]triolein with [l4C]trio1ein (a), [14C]tri-y- 
linolenin (b) or [14C]tripalmitin (c-f). The orlistat and the radiolabelled triacylglycerols were dissolved in olive oil 
(ax), coconut oil (d), cream (e) or palm oil (0. The orlistat was given at 0 (O), 3 (A), 10 (0) and 30 (0)  pmollkg 
body weight. Each value is from one mouse. The values from the control mice (0) were excluded from the linear 
regressions. Parameters derived from these regressions are given at the foot of the opposite page. 
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Table 4. Signijicance of the eflect of the fatty acid composition of radiolabelled 
triacylglycerols on the ability of orlistat to inhibit their absorption 
['4C]trilinolenin [14CC]trilinolenin ['Hltriolein v. 
v .  ['Hltriolein v. [14C]tripalmitin [14CJtripalmitin 
P P P 
In high-melting-point oil 
In meal 0006 0.015 0.9 17 
Post meal 0001 0021 0,913 
In meal 0.000 1 
Post meal 0.00 1 
In low-melting-point oil 
Table 5 .  Comparison of the orlistat-induced loss of radiolabelled triolein in the faeces of 
mice when the orlistat and the radiolabel are given in the same or diflerent test meals* 
(Mean values with their standard errors for three mice) 
Faecal loss (expressed as % intake) ... [3H]triolein [l4Cjtriolein 
Orlistat @mol/kg body wt) Mean SE Mean SE 
3 15.0 6.0 SO 4-0 
10 39.0 13.0 21.0 10.0 
30 66.0 7.0 50.0 9.0 
* Each mouse was orally administered two test meals, one after the other. Both test meals, which contained 
olive oil as the dietary lipid, had the same composition except that, in addition, the first contained orlistat plus 
['H]triolein and the second [14C]triolein. For further details, see p. 854. 
of unity and an intercept of approximately zero (Fig. 2a). However, a plot of ["Cltri-y- 
linolenin against [3H]triolein was apparently curvilinear, in that although the elimination 
of both radiolabels was < 2% in the absence of orlistat (Table 2), in its presence the 
elimination of [14C]tri-y-linolenin was up to 20 % larger than that of [3H]triolein (Fig. 2 b). 
Plots of the elimination of [14C]tripalmitin against [3H]triolein were also linear (Fig. 2c-9. 
When the dietary lipid was olive oil or coconut oil the slope was about I and the intercept 
close to zero (Fig. 2c and d). In contrast, when the dietary lipid was cream or palm oil the 
slopes were less than unity (0.89 and 0.76 respectively) and there were intercepts of 15 and 
21 YO respectively, on the [14C]tripalmitin axis (Fig. 2e and 0. These intercepts (see legend 
Fig. 2 (cont.) 
Confidence 
limits 95 YO 
Figure Slope SD ('YO) ('YO) (%) 
a 1.00 0.01 -0.1 -1 1 
b 0.80 0.04 23 16 30 
C 1.01 0.03 -3 -8 1 
d 0.95 0.03 -0.4 -5 5 
e 0.89 0.09 15 4 26 
f 0.76 0.09 21 7 3s 
Intercept 
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to Fig. 2)  were higher than the level of [14C]tripalmitin elimination found in mice that were 
not treated with orlistat (Table 2). 
In-meal v. extra-meal administration of orlistat 
When mice were administered a test meal that contained orlistat plus [3H]triolein and then, 
immediately afterwards, a second that contained [14C]triolein alone, the elimination of the 
rH]triolein was consistently larger than that of the [14C]triolein (Table 5). This is in contrast 
to the results shown in Fig. 2a, which show that when both radiolabels were incorporated 
into the same test meal orlistat inhibited their absorption to the same extent. 
DISCUSSION 
As triacylglycerol absorption is usually complete, it is difficult to assess in vivo whether the 
substrate specificity of gastrointestinal lipases is the same for all triacylglycerols. In order 
to assess this, under reasonably physiological conditions, we tested the effect of orlistat on 
the absorption of three very different radiolabelled triacylglycerols (tripalmitin, triolein and 
tri-y-linolenin) from a variety of plant oils as well as from cream. The dietary lipids were 
chosen to give a spectrum of fatty acid compositions, iodine values and melting points 
similar to that of the triacylglycerols found in the human diet (Table 1). The radiolabels 
were chosen to represent saturated, unsaturated and highly unsaturated dietary 
triacylglycerols. However, this choice was determined by availability rather than 
resemblance to naturally occurring triacylglycerols. The only advantage of triacylglycerols 
that are uniformly substituted with the same fatty acid is the simplicity of their synthesis, 
which leads directly to chemically defined molecules. The term triacylglycerol absorption, 
although not strictly correct, is a convenient description for the overall process of 
triacylglycerol hydrolysis and the subsequent absorption of the liberated fatty acids and 
monoacylglycerols. It is especially convenient as in vivo the two underlying processes are 
difficult to observe separately. However, as orlistat inhibits triacylglycerol hydrolysis and 
not fatty acid absorption (Fernandez & Borgstrom, 1989; see also Fig. l), an orlistat- 
induced increase in radiolabel in the faeces from radiolabelled dietary triacylglycerols 
should mainly monitor its effect on triacylglycerol hydrolysis. 
In the absence of orlistat, radiolabelled tri-y-linolenin and triolein were almost 
completely absorbed (> 97 %) by mice from all the dietary fats (Table 2). However, the 
absorption of radiolabelled tripalmitin depended on the oil; it was about 99 YO when the 
dietary lipid was olive oil, about 97 % when it was coconut oil and about 90 YO when it was 
cream or palm oil (Table 2). This is not usually observed (Bonanome & Grundy, 1988) and 
may result from the faster gastrointestinal transit after oral administration of a liquid test 
meal than after eating a normal meal (after 7 h we found > 90% of the nonabsorbable 
marker, [3H]polyethyleneglycol, in the faeces following an orally administered meal as 
opposed to about 60 YO following a normal meal). Previous studies in rats have shown that 
both palmitic and stearic acids require a greater length of intestine for their absorption than 
do linoleic and oleic acids (Ockner et al. 1972; Bergstedt et al. 1990) and, further, that the 
absorption of palmitic acid is more easily decreased than that of linoleic by increasing the 
palmitic acid load (Ockner et al. 1972). However, the present results do not distinguish 
between incomplete hydrolysis of tripalmitin and incomplete absorption of palmitic acid. 
A least-squares, nonlinear curve-fitting procedure was used to derive an ID,, for the 
inhibition of triacylglycerol absorption from the data. In the absence of a theoretical model 
an exponential relationship between dose and response was assumed in which both the 
maximal level of inhibition and the ID,, were determinable parameters (see equations 1 and 
available at https:/www.cambridge.org/core/terms. https://doi.org/10.1079/BJN19950090
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 10 Jul 2017 at 15:59:30, subject to the Cambridge Core terms of use,
ORLISTAT AND TRIACYLGLYCEROL ABSORPTION 861 
2). Using equation 1 or, where the radiolabel was eliminated in the faeces in the absence 
of orlistat, equation 2, the maximal inhibition was found to be approximately 80% (e.g. 
Fig. 1). Neither the nature of the radiolabelled triacylglycerol nor that of the dietary fat 
appeared to influence this value. One explanation for the maximal inhibition being less than 
100% is that before orlistat can bind covalently to the lipase it has to compete with the 
dietary triacylglycerol for access to the substrate binding site. However, t h s  is unlikely to 
be the only factor, as the maximal elimination of dietary triacylglycerol does not depend 
on the amount of triacylglycerol in the test meal (D. Isler, unpublished results). 
The dose of orlistat required to decrease absorption to 50 % (ID5,) of the extrapolated 
maximal value was between 2 and 4 times larger when the orlistat was given after the test 
meal compared with when it was dissolved in the lipids of the test meal (Table 3). Evidently, 
while in the stomach, orlistat suspended in a 50 g gum arabic plus 50 g milk-powder/l 
vehicle does not fully incorporate into the dietary lipids of the test meal we used. A possible 
explanation is that the low solubility of orlistat in water retards its transfer into the lipid 
phase containing the radiolabelled marker. We also found, when a test meal containing 
[3H]triolein plus orlistat was administered immediately before a test meal containing only 
[14C]triolein, that the absorption of [14C]triolein was less inhibited than that of [3H]triolein 
(compare the results in Table 5 with those in Fig. 2a). Evidently, the complete equilibration 
of components between different lipid phases in the stomach does not always occur. 
The ID,, for the inhibition of lipase activity by orlistat cannot depend on the 
radiolabelled triacylglycerol as this is present only in trace amounts. Therefore, as the ID,, 
for the inhibition of radiolabelled triolein absorption is higher than that of tri-y-linolenin 
(Table 3), it follows that triolein is a better substrate for gastrointestinal lipases than tri- 
y-linolenin. This is consistent with the results of Lawson & Hughes (1988) who found, in 
vitro, that pancreatic lipase was less efficient at hydrolysing y-linolenic acid than a-linolenic 
acid, and most other fatty acids, from plant triacylglycerols. The effect of orlistat on the 
absorption of y-linolenic acid is therefore not representative of its effect on the absorption 
of essential and polyunsaturated fatty acids in general. The ID,, for the inhibition of 
radiolabelled triolein absorption is independent of the melting point of the dietary lipid and 
of whether the orlistat is given after the test meal or dissolved in the lipids of the test meal 
(Table 3). The same is true for tri-y-linolenin when administered after the test meal, but 
when it is dissolved in the lipids of the test meal the ID,, is slightly smaller if they have a 
low, as opposed to a high, melting point (2-5 v.  3.8, P = 0.012, Table 3). 
It is generally assumed that radiolabelled triacylglycerols are best as markers for those 
triacylglycerols they most resemble. However, the extent to which radiolabelled 
triacylglycerols that contain a single fatty acid species resemble and report on dietary 
triacylglycerols is not known. Our results show that the absorption of [14C]tri-y-linolenin 
is more easily inhibited by orlistat than is that of [14C]triolein (Fig. 2 and Table 3), and that 
under certain conditions although the absorption of [14C]triolein and [14C]tri-y-linolenin is 
complete, that of [14C]tripalmitin is about 90% (Fig. 2e and f and Table 2). 
In conclusion, orlistat can be used to investigate triacylglycerol hydrolysis and absorption 
under physiological conditions in the intact animal and may therefore provide a useful tool 
to elucidate the different processes that occur in fat absorption. 
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